LOCOID Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Locoid patents expire, and what generic alternatives are available?
Locoid is a drug marketed by Bausch, Yamanouchi, and Precision Dermat. and is included in eight NDAs. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in LOCOID is hydrocortisone butyrate. There are sixty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Locoid
A generic version of LOCOID was approved as hydrocortisone butyrate by TARO PHARM INDS on January 14th, 2004.
Summary for LOCOID
| US Patents: | 2 |
| Applicants: | 3 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Clinical Trials: | 4 |
| Patent Applications: | 5,276 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LOCOID |
| What excipients (inactive ingredients) are in LOCOID? | LOCOID excipients list |
| DailyMed Link: | LOCOID at DailyMed |
Recent Clinical Trials for LOCOID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| LEO Pharma | Phase 1 |
| Icahn School of Medicine at Mount Sinai | N/A |
| St. Luke's-Roosevelt Hospital Center | Phase 4 |
Pharmacology for LOCOID
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for LOCOID
Paragraph IV (Patent) Challenges for LOCOID
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| LOCOID | Lotion | hydrocortisone butyrate | 0.10% | 022076 | 1 | 2016-08-31 |
US Patents and Regulatory Information for LOCOID
LOCOID is protected by two US patents.
Patents protecting LOCOID
Stabilized steroid composition and method for its preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Stabilized steroid composition and method for its preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | LOCOID | hydrocortisone butyrate | CREAM;TOPICAL | 018514-001 | Mar 31, 1982 | AB1 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Bausch | LOCOID | hydrocortisone butyrate | SOLUTION;TOPICAL | 019116-001 | Feb 25, 1987 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Bausch | LOCOID | hydrocortisone butyrate | LOTION;TOPICAL | 022076-001 | May 18, 2007 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| Yamanouchi | LOCOID | hydrocortisone butyrate | SOLUTION;TOPICAL | 019819-001 | Sep 15, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Premature patent expiration for: LOCOID
Expiration due to failure to pay maintenance fee
| Patent Number | Tradename | Expiration Date |
|---|---|---|
| ⤷ Try a Trial | LOCOID | ⤷ Try a Trial |
